AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 SEP 2 - (NewsRx.com & NewsRx.net) -- The Infectious Diseases Society for Obstetrics & Gynecology featured HPV (human papillomavirus) testing at its annual meeting in a symposium titled "New Diagnostics: Changing Paradigms," which included a focus on the test's emerging role as a standard of care in cervical cancer screening.
Digene Corp. (DIGE) has developed the only HPV test approved by the U.S. Food and Drug Administration FDA for routine screening, marketed as the DNAwithPap Test, for use in conjunction with a Pap test in women 30 and older.
In a presentation at the symposium, J. Thomas Cox, MD, director of the Gynecology and Colposcopy Clinic at the University of California at Santa Barbara, California, reviewed data from numerous studies showing that testing for the HPV - the primary cause of cervical cancer - is more accurate than a single Pap test in identifying women with ...